KV-PREDICT Diagnostic Device in Patients With Heart Failure

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 120 participants.

Also called NCT07805213

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 120 participants (planned count) (from the registry)
Sponsor
KardioVis S.r.l. (from the registry)
Registry
  • NCT NCT07805213
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Italy (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07805213. Allocation not applicable; no masking; primary purpose diagnostic. Start 2026-09 (anticipated); primary completion 2027-04 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
KV-PREDICT Diagnostic Device in Patients With Heart Failure
Acronym
PREDICT_HF
Condition
Heart Failure
Intervention (Device)
KV-PREDICT
Lead sponsor
KardioVis S.r.l. (class: industry)

Record details

Record id
cardio:ct-nct07805213
Content hash
7b9472819ed83acfedc577f29e939eee13071bba24142883f59807d6b9857fc0